Crinetics Pharmaceuticals, Inc. Deferred Revenue, Revenue Recognized
Crinetics Pharmaceuticals, Inc. (CRNX) reported Deferred Revenue, Revenue Recognized of $605.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2023-05-09
- Crinetics Pharmaceuticals, Inc. deferred revenue, revenue recognized for the quarter ending 2023-03-31 was $605.00K.
| Period end | Deferred Revenue, Revenue Recognized 3 month |
|---|---|
| 2023-03-31 | $605.00K 10-Q · filed 2023-05-09 |